Prevest Denpro Limited targets digital dentistry, Rs 81.14 lakh R&D
Key highlights
- Prevest Denpro spent Rs 81.14 lakh on R&D in H1 FY27.
- Prevest Denpro reported 59% export revenue share in H1 FY27.
- Prevest Denpro reported 14.90% H1 FY27 year-on-year export revenue growth.
- Prevest Denpro serves more than 90 export destinations.
powered by IRIS

Prevest Denpro spent Rs 81.14 lakh on research and development in H1 FY27 while developing in-house 3D-printer capabilities and specialized dental printing resins. The company’s stated objective is to move from dental materials into integrated digital dentistry solutions, with high-strength biocompatible resins for permanent crowns among its disclosed projects.
Know Prevest Denpro inside out
Results, valuation, peers and who's buying, in one view.
What is Prevest Denpro’s digital dentistry strategy?
Prevest Denpro’s strategy is to expand from dental materials into integrated digital dentistry solutions built around dental 3D printing. Its stated programme includes expanding dental 3D-printing solutions, developing in-house 3D-printer capabilities, increasing its portfolio of specialized dental printing resins and integrating printing solutions with dental-material applications.
The planned offering sits alongside an existing product ecosystem covering restorative materials, endodontic solutions, preventive care, orthodontic adhesives, and impression materials and cements. The digital dentistry and disinfectants category already includes 3D-printing resins, computer-aided design/computer-aided manufacturing, or CAD/CAM, materials, and surface disinfectants.
The shift is an objective rather than a disclosed completed product launch. Prevest Denpro says it intends to become a broader provider of integrated digital dentistry solutions, while its FY27 roadmap refers to a complete dental 3D-printing ecosystem, specialized resin solutions and integrated restorative solutions.
How much is Prevest Denpro spending on research and development?
Prevest Denpro reported Rs 81.14 lakh of research and development expenditure in H1 FY27. The presentation places this spending within dedicated R&D infrastructure for next-generation product development and identifies 3D printing, endodontics, restoratives, preventive care and hygiene as workstreams.
The R&D disclosure does not split the Rs 81.14 lakh H1 FY27 total among its five product areas. It specifically identifies high-strength biocompatible resins for permanent crowns in 3D printing, directly linking part of the disclosed development agenda to the digital dentistry programme.
Prevest Denpro reported 14.90% year-on-year export revenue growth in H1 FY27, compared with 17.58% in FY26, a difference of 2.68 percentage points. The periods are not directly equivalent because one is a full-year measure and the other is half-year growth, but the disclosed H1 FY27 rate was lower.
Prevest Denpro also reported an H1 FY27 revenue mix of 59% exports and 41% domestic revenue. This provides commercial context for the product plan, as the company is developing specialized resins and digital workflows while seeking international expansion and domestic new-category launches.
Got a follow-up? Ask IRIS
Which products are included in Prevest Denpro’s R&D pipeline?
Prevest Denpro’s disclosed R&D pipeline includes high-strength biocompatible resins for permanent crowns, bioceramic sealers with enhanced bioactivity, nano-hybrid universal composites, advanced remineralising pastes and hospital-grade eco-friendly surface disinfectants. These projects cover the 3D-printing, endodontic, restorative, preventive and hygiene segments.
The permanent-crown resin project is the clearest disclosed connection to the planned 3D-printing ecosystem. The other projects support categories already present in Prevest Denpro’s portfolio, including root-canal materials, aesthetic restoration products, preventive-care products and disinfectants.
Prevest Denpro also cites in-house research, formulation and product-development capabilities at its Jammu manufacturing infrastructure. Its operating programme includes indigenous raw-material development to reduce import dependence, together with process automation, quality-management systems and regulatory compliance.
How does the FY27 roadmap support Prevest Denpro’s digital dentistry plan?
Prevest Denpro’s FY27 roadmap supports the digital dentistry plan through product and technology development, market expansion and operational resilience. Its product track calls for expanded digital workflows, integrated restorative solutions and a complete dental 3D-printing ecosystem including specialized resin solutions.
The market-expansion track pairs product development with domestic fortification in Tier II and Tier III markets through targeted new-category launches. Internationally, Prevest Denpro says it is entering new markets and scaling exports to additional countries, building on more than 90 export destinations and a 59% export share in H1 FY27.
Prevest Denpro’s international structure includes direct United States presence through subsidiary Axiomdent Inc., distribution-network expansion in the Middle East and Africa through a United Arab Emirates subsidiary, and the Prevest Direct ecommerce platform for global distributors. The presentation does not quantify digital-dentistry sales through these channels.
The operational-resilience track focuses on indigenous critical dental raw materials to reduce import reliance and secure the production line. This mechanism is relevant to the printing-resin and wider dental-material plan because Prevest Denpro links local raw-material development, process automation and manufacturing efficiency to its Jammu operating capability.
Conclusion
Prevest Denpro is pursuing a broader dental-technology position through in-house 3D-printer development, specialized resins and integration with restorative applications, supported by Rs 81.14 lakh of H1 FY27 R&D expenditure. The pipeline also spans permanent-crown resins, bioceramic sealers, nano-hybrid composites, remineralising pastes and disinfectants, while exports accounted for 59% of H1 FY27 revenue.
The next disclosed items to watch are the FY27 roadmap actions: expansion of digital workflows and specialized resin solutions, new-category launches in Tier II and Tier III markets, entry into additional international markets and localization of critical dental raw materials. Prevest Denpro has stated these as plans, while the presentation does not disclose a printer launch date, a digital-product revenue target or separate sales for the new portfolio.


